SHL Telemedicine Announces 2025 Half-Year Results and Capital Raise
Ticker: SHMLF · Form: 6-K · Filed: Sep 11, 2025 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Sep 11, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: results, capital-raise
TL;DR
SHL Telemedicine dropped 2025 half-year results and is looking to raise capital.
AI Summary
On September 11, 2025, SHL Telemedicine Ltd. announced its half-year results for 2025 and revealed plans for a capital raise. The company issued a press release detailing these updates, which is being furnished to the SEC.
Why It Matters
This filing signals potential new funding for SHL Telemedicine, which could impact its growth and operational capacity, and provides investors with recent financial performance data.
Risk Assessment
Risk Level: medium — The company is announcing financial results and a capital raise, which introduces uncertainty and potential volatility.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- September 11, 2025 (date) — Date of press release and filing
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose is to furnish a press release dated September 11, 2025, titled 'SHL announces 2025 half-year results and targets a capital raise', as an exhibit.
What period do the announced results cover?
The announced results cover the half-year of 2025.
What is SHL Telemedicine Ltd.'s principal executive office address?
The address is 90 Yigal Alon Street, Tel Aviv 67891, Israel.
Does SHL Telemedicine Ltd. file annual reports under Form 20-F or 40-F?
The company files annual reports under cover of Form 20-F.
What is the Commission File Number for SHL Telemedicine Ltd.?
The Commission File Number is 001-41641.
Filing Stats: 229 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2025-09-11 06:00:41
Filing Documents
- zk2533775.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 13KB
- image0.jpg (GRAPHIC) — 135KB
- image1.jpg (GRAPHIC) — 112KB
- 0001178913-25-003289.txt ( ) — 365KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL TELEMEDICINE LTD. By: /s/ Lior Haalman Lior Haalman Chief Financial Officer September 11, 2025 3